Latest News
-
PARIS, France and CAMBRIDGE, MA, USA – Sanofi and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for the treatment of rare genetic diseases. Specifically: Sanofi will obtain global development and commercialization rights... -
VANCOUVER, British Columbia – Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, provided key accomplishments from the past year and announced priorities for 2018. “2017 was a great year for Zymeworks and we are poised to achieve a number of important corporate milestones in 2018,” said Ali Tehrani,...
-
Alzheimer’s disease is a devastating brain illness that affects an estimated 47 million people worldwide. It is the most common cause of dementia in the Western world. Despite this, there are currently no treatments that are effective in curing Alzheimer’s disease or preventing its relentless progression. Alzheimer’s disease is caused...
Videos
Rare disease spotlight
Read this inspiring article on how PhD student Katherine Gulliver’s personal experience of Williams Syndrome, influenced her further educational and professional paths. We are lucky to have Katherine as part of our Regional contacts team for Devon and Somerset. https://twitter.com/PlymUni/status/1265272895845986310
Our BA Education degree isn't just for future teachers.
Find out how the course inspired PhD student Kat Gulliver to study inclusive education abroad, and how her knowledge has supported her charity work with @HCPT and @WSF_UK
Find out more 👇
https://www.plymouth.ac.uk/courses/undergraduate/ba-education/katherine-gulliver
Have you signed up to be a part of #BeyondXLH, the Disease Monitoring Program for #XLH yet? http://www.BeyondXLH.com #StrongDataStrongerLives
This summer, we are pleased to introduce a series of leadership skill-building webinars for Young Adult Representatives of RDLA (YARR) members.
2